Skip to main content

Table 2 Treatment outcome

From: Clinicopathological features and treatment outcome of central neurocytoma: a single institute experience

Outcome N (total n = 17) %
Alive   
 Yes 17 100
 No 0 0
Recurrence rate   
 No recurrence 13 76.5
 Recurrencea 4 23.5
5-year progression free survival 70 ± 13%
Median time to progression (months) 39 (11–48)
  1. aTwo patients had 1 recurrence, 1 patient had 2 recurrences and 1 patient had 3 recurrences